Email Updates

Search form

You are here

Browse and Order Resources

AVAC is excited to share our annual “state of the field” report on biomedical prevention research and implementation. AVAC Report 2017: Mixed Messages and How to Untangle Them is straight talk about today’s complex context for HIV prevention. Read this report if you’ve wondered that there’s more rhetorical support than ever for HIV prevention but no more money? How can the world be “on the path to epidemic control” while human rights are trampled in many places, and rates of HIV diagnoses climb in others?

November 2017
AVAC
General
AVAC Report

This annual accounting of funding for biomedical HIV prevention research tracks trends and identifies gaps in investment. In 2016, funding for HIV prevention R&D decreased by US$35 million from the previous year to a total of US$1.17 billion. This marks the lowest recorded annual investment in more than a decade. While investments toward research in preventive vaccines, PrEP and medical male circumcision increased in 2016, funding for microbicides, treatment as prevention, female condoms and prevention of vertical transmission decreased.

July 2017
The Resource Tracking for HIV Prevention R&D Working Group
AVAC
IAVI
Report/Issue Brief

PrEP works if you take it. The figures on this graphic show the relationship between PrEP efficacy and adherence and the status of regulatory action on PrEP worldwide. It also shows other potential new formulations of ARV-based prevention being evaluated as additional options in the future.

August 2016
AVAC
By The Numbers
Infographic

We know that an AIDS vaccine is possible and that a vaccine will be an important part of a long-term strategy to end the AIDS epidemic. The road ahead is long, but clinical trials—even those with disappointing results—and early-stage research provide critical clues to the way forward. The graphics below represent key facts about the AIDS vaccine field.

May 2016
AVAC
By The Numbers
Infographic

The term “microbicide” refers to substances being studied that could be used in the vagina and/or rectum to reduce the risk of HIV infection via sexual exposure. There are no licensed microbicides available today. Simple, easy-to-use microbicides would help these individuals take control of their own health—while offering people everywhere an additional, needed option. The graphics below represent key facts about the microbicide field.

July 2016
AVAC
By The Numbers
Infographic

A handbook designed to guide the user through various communication scenarios. The handbook offers tips and strategies to navigating difficult scenarios that may occur throughout the clinical trial process. It also offers suggestions on routine scenarios such as result dissemination and training staff and spokespersons.

February 2014
FHI 360
Handbook/Manual
Training Material

A comprehensive 2012 report from civil society about the state of voluntary medical male circumcision in Africa. Includes priority recommendations and in-depth discussion of factors influencing national scale-up efforts.  

July 2012
AVAC
National Empowerment Network of People Living with HIV/AIDS in Kenya
Sonke Gender Justice Network
Uganda Network of AIDS Service Organizations
Report/Issue Brief

The Good Participatory Practice (GPP) guidelines offer trial funders, sponsors and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle of HIV Prevention Trials. This second edition of the guidelines, published in 2011, contains three sections: The Importance of Good Participatory Practice, Guiding Principles of GPP in Biomedical HIV Prevention Trials and Good Participatory Practices in Biomedical HIV Prevention Trials. The sections provide context, foundational principles and key practices.

June 2011
AVAC
UNAIDS
Handbook/Manual
Training Material

The Handbook provides comprehensive introductory material on the key scientific, policy, social, ethical and economic facets of AIDS vaccine research. While the science has changed greatly over the decade since this second edition of the Handbook was published in 2005, the themes and content in many of the essays still hold true. Edited by Patricia Kahn, the handbook contains articles by community educators and advocates, trial staff and volunteers, scientists and researchers, and policy makers and journalists.

May 2005
AVAC
Edited by Patricia Kahn
Handbook/Manual